Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections.
Eilish McCannAnita H SungGang YeLatha VankeepuramYing P TabakPublished in: ClinicoEconomics and outcomes research : CEOR (2020)
Hospital-onset infections, polymicrobial infections, higher clinical severity, and underlying diseases are key predictors for worsened overall burden of carbapenem-nonsusceptible gram-negative UTIs.